NCT02103673View on ClinicalTrials.gov

DAOIB for the Treatment of Cognitive Function and Behavioral and Psychological Symptoms of Dementia

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2017

Conditions
Behavioral and Psychological Symptoms in Alzheimer's DiseaseBehavioral and Psychological Symptoms in Vascular Dementia
Interventions
DRUG

DAOIB

Intervention drug: DAOIB. Dosage: 250-1500 mg/day by mouth. Duration: 6 weeks

DRUG

Placebo

Intervention drug: placebo by mouth. Duration: 6 weeks

Trial Locations (2)

886

Chang Gung Memorial Hospital, Kaohsiung City

China Medical University Hospital, Taichung

All Listed Sponsors
lead

Chang Gung Memorial Hospital

OTHER

NCT02103673 - DAOIB for the Treatment of Cognitive Function and Behavioral and Psychological Symptoms of Dementia | Biotech Hunter | Biotech Hunter